首页期刊导航|结合医学学报(英文版)
期刊信息/Journal information
结合医学学报(英文版)
结合医学学报(英文版)

赵伟康

月刊

2095-4964

jcim@163.com

021-81873540

200433

上海市杨浦区翔殷路800号第二军医大学中医系2201室

结合医学学报(英文版)/Journal Journal of Chinese Integrative MedicineCSCDCSTPCD北大核心SCI
查看更多>> 《中西医结合学报》于2003年5月创刊,是中国科技论文统计源期刊、中国科技核心期刊、RCCSE中国权威学术期刊、上海市科协系统优秀科技期刊、全国中医药优秀期刊、美国《医学索引》(Index Medicus/MEDLINE/PubMed)收录期刊。 《中西医结合学报》是开放获取期刊,已被列入《开放获取期刊指南》(Directory of Open Access Journals, DOAJ),所有被录用的稿件均经过同行评议,同时在纸质印刷版和网络电子版发表。 《中西医结合学报》为月刊,设有院士笔谈、专论、述评、学术探讨、系统评价、临床论著、实验论著、经验交流、医案医话、文献研究、文献综述、学术讲座、医学统计学、中医英译、结合医学概览、医学论文写作、国际动态、会议消息、书评、招聘启事、读者来信等栏目。纸质印刷版于每月15日出版,全球发行;网络电子版与纸质印刷版同步出版。网络电子版具有完善的检索和参考文献链接功能。全球用户可在本刊中英文双语网站无任何限制地检索、阅读和下载全部论文。 《中西医结合学报》在国际最权威的医学文献电子数据库PubMed建有免费全文链接。全球用户可在PubMed免费检索任何一篇论文的摘要和题录,并且可以在PubMed即时链接本刊网站,免费阅读所检索的论文全文。 中西医结合学报杂志社(JCIM Press)是出版者国际链接联合会(Publisher International Linking Association, PILA)和CrossRef的机构会员,与CrossRef成员期刊实现了跨平台链接。《中西医结合学报》的每一篇论文都注册了DOI号,并建有参考文献链接和被引链接。 《中西医结合学报》将以最快的速度,最便捷的方式,最大范围地向世界展示您的研究成果。 我们的办刊方针:坚持学术期刊的导向作用,履行学术期刊的社会责任,倡导科学、严谨、务实、创新的学术风尚。我们的办刊理念:只争朝夕,只求卓越;尽我所能,做到更好。 我们的办刊目的:向世界展示中国中西医结合研究的成果,向中国读者介绍世界结合医学的进展,为全球读者提供一个即时和自由交流的学术平台。 我们的办刊方向:编辑出版国际一流医学期刊,打造国际化精品期刊、品牌期刊。
正式出版
收录年代

    A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin

    Xin-yang LiuWei XieHe-yang ZhouHui-qing Zhang...
    621-636页
    查看更多>>摘要:Natural product-based antiviral candidates have received significant attention.However,there is a lack of sufficient research in the field of antivirals to effectively combat patterns of drug resistance.Baicalein and its glucuronide derivative baicalin are two main components extracted from Scutellaria baicalensis Georgi.They have proven to be effective against a broad range of viruses by directly killing virus particles,pro-tecting infected cells,and targeting viral antigens on their surface,among other mechanisms.As natural products,they both possess the advantage of lower toxicity,enhanced therapeutic efficacy,and even antagonistic effects against drug-resistant viral strains.Baicalein and baicalin exhibit promising potential as potent pharmacophore scaffolds,demonstrating their antiviral properties.However,to date,no review on the antiviral effects of baicalein and baicalin has been published.This review summarizes the recent research progress on antiviral effects of baicalein and baicalin against various types of viruses both in vitro and in vivo with a focus on the dosages and underlying mechanisms.The aim is to provide a basis for the rational development and utilization of baicalein and baicalin,as well as to promote antiviral drug research.

    Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19:A multicenter randomized controlled trial

    Xuan YinZhu JinFeng LiLi Huang...
    637-644页
    查看更多>>摘要:Background:The outbreak of coronavirus disease 2019(COVID-19)infection posed a huge threat and bur-den to public healthcare in late 2022.Non-drug measures of traditional Chinese medicine(TCM),such as acupuncture,cupping and moxibustion,are commonly used as adjuncts in China to help in severe cases,but their effects remain unclear.Objectives:To observe the clinical effect of TCM non-drug measures in improving respiratory function and symptoms among patients with severe COVID-19.Design,setting,participants and interventions:This study was designed as a multicenter,assessor-blind,randomized controlled trial.Hospitalized patients with COVID-19 were randomly assigned to the treat-ment or control group.The treatment group received individualized TCM non-drug measures in combi-nation with prone position ventilation,while the control group received prone position ventilation only for 5 consecutive days.Main outcome measures:The primary outcome measures were the percentage of patients with improved oxygen saturation(SpO2)at the end of the 5-day intervention,as well as changes of patients'respiratory rates.The secondary outcome measures included changes in SpO2 and total score on the self-made res-piratory symptom scale.The improvement rate,defined as a 3-day consecutive increase in SpO2,the duration of prone positioning,and adverse events were recorded as well.Results:Among the 198 patients included in the intention-to-treat analysis,159(80.3%)completed all assessments on day 5,and 39(19.7%)patients withdrew from the study.At the end of the intervention,71(91%)patients in the treatment group had SpO2 above 93%,while 61(75.3%)in the control group reached this level.The proportion of participant with improved SpO2 was significantly greater in the intervention group(mean difference[MD]=15.7;95%confidence interval[CI]:4.4,27.1;P=0.008).Compared to the baseline,with daily treatment there were significant daily decreases in respiratory rates in both groups,but no statistical differences between groups were found(all P ≥ 0.05).Compared to the control group,the respiratory-related symptoms score was lower among patients in the treatment group(MD=-1.7;95%CI:-2.8,-0.5;P=0.008)after day 3 of treatment.A gradual decrease in the total scores of both groups was also observed.Thirty-one adverse events occurred during the intervention,and 2 patients were transferred to the intensive care unit due to deterioration of their illness.Conclusion:TCM non-drug measures combined with prone positioning can effectively treat patients with severe COVID-19.The combined therapy significantly increased SpO2 and improved symptom scores compared to prone positioning alone,thus improving the patients'respiratory function to help them recover.However,the improvement rate did not differ between the two groups.

    Clinical efficacy of Xuebijing injection for the treatment of sepsis:A retrospective cohort study

    Zhao-tang GongHong-xin YangBen-ben ZhuHuan-huan Liu...
    645-651页
    查看更多>>摘要:Objective:The objective of this study was to investigate the clinical efficacy and safety of treating sepsis patients with Xuebijing injection(XBJI).Methods:We conducted a retrospective analysis of 418 patients who experienced severe infections and were treated with XBJI from June 2018 to June 2021.Propensity score matching was used to match the patient cases.The study population included 209 pairs of cases(418 individuals),and the analysis included data from before and after a 14-day course of treatment with carbapenem alone,or carbapenem with XBJI.Results:There were no significant differences in the 14-day mortality or length of hospital stay(P>0.05)between the two groups.The combined treatment group had more patients with C-reactive protein that returned to normal levels(compared to baseline)than the non-combined treatment group(14.4%vs 8.1%;odds ratio[OR]:0.528;95%confidence interval[CI]:0.282-0.991;P=0.026).Similarly,the combined treatment group had higher procalcitonin attainment rate(55.0%vs 39.7%;OR:0.513;95%CI:0.346-0.759;P=0.001)than the non-combined treatment group.Further,more patients in the combined treat-ment group achieved normal creatinine levels than in the non-combined treatment group(64.1%vs 54.1%;OR:0.659;95%CI:0.445-0.975;P=0.037).Conclusion:The combination of XBJI with carbapenem did not reduce the 14-day mortality rate of patients with severe infection,but it was able to reduce the level of inflammatory factors in patients with sepsis,and had a protective effect on liver and kidney function.

    Luteolin protects against myocardial ischemia/reperfusion injury by reducing oxidative stress and apoptosis through the p53 pathway

    Pan ZhaiXiao-hu OuyangMeng-ling YangLan Lin...
    652-664页
    查看更多>>摘要:Objective:Myocardial ischemia/reperfusion injury(MIRI)is an obstacle to the success of cardiac reperfu-sion therapy.This study explores whether luteolin can mitigate MIRI by regulating the p53 signaling pathway.Methods:Model mice were subjected to a temporary surgical ligation of the left anterior descending coronary artery,and administered luteolin.The myocardial infarct size,myocardial enzyme levels,and cardiac function were measured.Latent targets and signaling pathways were screened using network pharmacology and molecular docking.Then,proteins related to the p53 signaling pathway,apoptosis and oxidative stress were measured.Hypoxia/reoxygenation(HR)-incubated HL1 cells were used to val-idate the effects of luteolin in vitro.In addition,a p53 agonist and an inhibitor were used to investigate the mechanism.Results:Luteolin reduced the myocardial infarcted size and myocardial enzymes,and restored cardiac function in MIRI mice.Network pharmacology identified p53 as a hub target.The bioinformatic analyses showed that luteolin had anti-apoptotic and anti-oxidative properties.Additionally,luteolin halted the activation of p53,and prevented both apoptosis and oxidative stress in myocardial tissue in vivo.Furthermore,luteolin inhibited cell apoptosis,JC-1 monomer formation,and reactive oxygen species ele-vation in HR-incubated HL1 cells in vitro.Finally,the p53 agonist NSC319726 downregulated the protec-tive attributes of luteolin in the MIRI mouse model,and both luteolin and the p53 inhibitor pifithrin-αdemonstrated a similar therapeutic effect in the MIRI mice.Conclusion:Luteolin effectively treats MIRI and may ameliorate myocardial damage by regulating apop-tosis and oxidative stress through its targeting of the p53 signaling pathway.

    A herbal pair of Scutellaria barbata D.Don and Scleromitrion diffusum(Willd.)R.J.Wang induced ferroptosis in ovarian cancer A2780 cells via inducing heme catabolism and ferritinophagy

    Zhen WangMin LiuGuang-xing LiLiu Zhang...
    665-682页
    查看更多>>摘要:Objective:Despite the combination of Scutellaria barbata D.Don and Scleromitrion diffusum(Willd.)R.J.Wang(SB-SD)being a recognized Chinese medicinal herbal pair that is commonly used in the treatment of ovarian cancer,there is a poor understanding of their pharmacological mechanisms.This study exam-ines the antitumor properties and potential mechanisms of SB-SD on human ovarian cancer A2780 cells through a multi-omics approach,establishing a pharmacological basis for clinical utilization.Methods:A range of mass ratios and reagents were used in the hot reflux extraction of SB-SD.The inhibi-tory effect of the SB-SD extracts on A2780 cell proliferation was assessed using the cell-counting kit 8 assay.A zebrafish tumor implantation model was used to evaluate the effects of SB-SD extracts on tumor growth and metastasis in vivo.Transcriptomics and proteomics were used to investigate alterations in bio-logical pathways in A2780 cells after treatment with different concentrations of SB-SD extract.Cell cycle,cell apoptosis,intracellular free iron concentration,intracellular reactive oxygen species(ROS)concentra-tion,malondialdehyde(MDA),and mitochondrial membrane potential were measured.Real-time quanti-tative reverse transcription polymerase chain reaction and Western blotting were utilized to investigate the effects of heme catabolism and ferritinophagy on ferroptosis induced by SB-SD extract in A2780 cells.Results:The 70%ethanol extract of SB-SD(a mass ratio of 4:1)inhibited A2780 cell proliferation signifi-cantly with a half maximal inhibitory concentration of 660 μg/mL in a concentration-and time-dependent manner.Moreover,it effectively suppressed tumor growth and metastasis in a zebrafish tumor implantation model.SB-SD extract induced the accumulation of free iron,ROS,MDA,and mitochondrial damage in A2780 cells.The mechanisms might involve the upregulated expression of ferritinophagy-related genes microtubule-associated protein 1 light chain 3,autophagy-related gene 5,and nuclear receptor coactivator 4.Conclusion:SB-SD extract effectively inhibited the development of ovarian cancer both in vitro and in vivo.Its mechanism of action involved inducing ferroptosis by facilitating heme catabolism and ferritinophagy.This herbal pair holds promise as a potential therapeutic option for ovarian cancer treatment and may be utilized in combination with routine treatment to improve the treatment outcomes of ovarian cancer patients.

    Morin,a matrix metalloproteinase 9 inhibitor,attenuates endothelial-to-mesenchymal transition in atherosclerosis by downregulating Notch-1 signaling

    Yuan HeXiao-xuan QinMing-wei LiuWei Sun...
    683-695页
    查看更多>>摘要:Objective:Atherosclerotic cardiovascular disease poses a significant health challenge globally.Recent findings highlight the pivotal role of the endothelial-to-mesenchymal transition(EndMT)in atheroscle-rosis.Morin is a bioflavonoid mainly extracted from white mulberry,a traditional Chinese herbal medi-cine with anti-inflammatory and antioxidant properties.This study examines whether morin can alleviate atherosclerosis by suppressing EndMT and seeks to elucidate the underlying mechanism.Methods:We induced an in vitro EndMT model in human umbilical vein endothelial cells(HUVECs)by stimulating the cells with transforming growth factor-β1(TGF-β1)(10 ng/mL)for 48 h.The in vivo exper-iments were performed in an atherosclerosis model using apolipoprotein E(ApoE)-/-mice fed with a high-fat diet(HFD).Mice in the intervention group were given morin(50 mg/kg)orally for 4 weeks.Molecular docking and microscale thermophoresis were assayed to understand the interactions between morin and matrix metalloproteinase-9(MMP-9).Results:Morin inhibited the expression of EndMT markers in a dose-dependent manner in TGF-β1-treated HUVECs.Administering 50 μmol/L morin suppressed the upregulation of MMP-9 and Notch-1 sig-naling in TGF-β1-induced EndMT.Moreover,the overexpression of MMP-9 activated Notch-1 signaling,thereby reversing morin's inhibitory effect on EndMT.In the HFD-induced atherosclerotic ApoE-/-mice,morin notably reduced aortic intimal hyperplasia and plaque formation by suppressing EndMT.Furthermore,morin demonstrated a strong binding affinity for MMP-9.Conclusion:Morin acts as an MMP-9 inhibitor to disrupt EndMT in atherosclerosis by limiting the activa-tion of Notch-1 signaling.This study underscores morin's potential utility in the development of anti-atherosclerotic medication.

    Jiedu recipe,a compound Chinese herbal medicine,suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment

    Wen-tao JiaShuang XiangJin-bo ZhangJia-ying Yuan...
    696-708页
    查看更多>>摘要:Objective:Tumor-derived exosomes(TDEs)play crucial roles in intercellular communication.Hypoxia in the tumor microenvironment enhances secretion of TDEs and accelerates tumor metastasis.Jiedu recipe(JR),a traditional Chinese medicinal formula,has demonstrated efficacy in preventing the metastasis of hepatocellular carcinoma(HCC).However,the underlying mechanism remains largely unknown.Methods:Animal experiments were performed to investigate the metastasis-preventing effects of JR.Bioinformatics analysis and in vitro assays were conducted to explore the potential targets and active components of JR.TDEs were assessed using nanoparticle tracking analysis(NTA)and Western blotting(WB).Exosomes derived from normoxic or hypoxic HCC cells(H-TDEs)were collected to establish preme-tastatic mouse models.JR was intragastrically administered to evaluate its metastasis-preventive effects.WB and lysosomal staining were performed to investigate the effects of JR on lysosomal function and autophagy.Bioinformatics analysis,WB,NTA,and immunofluorescence staining were used to identify the active components and potential targets of JR.Results:JR effectively inhibited subcutaneous-tumor-promoted lung premetastatic niche development and tumor metastasis.It inhibited the release of exosomes from tumor cells under hypoxic condition.JR treatment promoted both lysosomal acidification and suppressed secretory autophagy,which were dysregulated in hypoxic tumor cells.Quercetin was identified as the active component in JR,and the epi-dermal growth factor receptor(EGFR)was identified as a potential target.Quercetin inhibited EGFR phos-phorylation and promoted the nuclear translocation of transcription factor EB(TFEB).Hypoxia-impaired lysosomal function was restored,and secretory autophagy was alleviated by quercetin treatment.Conclusion:JR suppressed HCC metastasis by inhibiting hypoxia-stimulated exosome release,restoring lysosomal function,and suppressing secretory autophagy.Quercetin acted as a key component of JR and regulated TDE release through EGFR-TFEB signaling.Our study provides a potential strategy for retarding tumor metastasis by targeting H-TDE secretion.

    Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor

    Xiong-hui WangYa-lan FuYan-nan XuPeng-cheng Zhang...
    709-718页
    查看更多>>摘要:Objective:Ginsenoside Rh1(G-Rh1)has been confirmed to inhibit the growth of breast cancer and colon cancer,but its therapeutic effect on hepatocellular carcinoma(HCC)is unclear.This study investigates the therapeutic effect of G-Rh1 on HCC as well as the underlying mechanism.Methods:Bioinformatics methods were used to analyze glucocorticoid receptor(GR)expression and the tumor microenvironment in HCC tissues from HCC patients.The effect of G-Rh1 on HCC cells was inves-tigated in vitro using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method.The therapeutic effect of G-Rh1 was investigated in vivo using subcutaneous transplantation models in C57BL/6J and nude mice.Additionally,the proportion of infiltrating immune cells in tumors was analyzed using flow cytometry,the GR and major histocompatibility complex class-I(MHC-I)expression of HCC cells after G-Rh1 treatment was analyzed using Western blotting,and G-Rh1-treated Hepa1-6 cells were cocultured with bone marrow-derived dendritic cells and B3Z T cells to further analyze the ability of G-Rh1 to induce dendritic cell(DC)maturation and CD8+T cell activation.Results:GR expression was upregulated in HCC tissues,and high GR expression was associated with a worsened immune microenvironment.In vitro studies showed that G-Rh1 had no significant effect on the proliferation of HCC cells,while in vivo studies showed that G-Rh1 exerted antitumor effects in C57BL/6J mice but not in nude mice.Further research revealed that G-Rh1 ameliorated the immunosup-pressive tumor microenvironment,thereby enhancing the antitumor effects of lenvatinib by increasing the infiltration of CD8+T cells,mature DCs,and MHC-I-positive cells.MHC-I was upregulated by G-Rh1 via GR suppression.Moreover,overexpression of GR abolished the G-Rh1-mediated promotion of MHC-I expression in Huh7 cells,as well as the maturation of DCs and the activation of CD8+T cells.Conclusion:G-Rh1 can regulate the immune microenvironment of HCC by targeting GR,thus increasing the antitumor effect of lenvatinib.

    Ginsenoside Rg1 promotes non-rapid eye movement sleep via inhibition of orexin neurons of the lateral hypothalamus and corticotropin-releasing hormone neurons of the paraventricular hypothalamic nucleus

    Yi-yuan WangYi WuKe-wei YuHong-yu Xie...
    719-728页
    查看更多>>摘要:Objective:This study investigates the sleep-modulating effects of ginsenoside Rg1(Rg1,C42H72O14),a key bioactive component of ginseng,and elucidates its underlying mechanisms.Methods:C57BL/6J mice were intraperitoneally administered doses of Rg1 ranging from 12.5 to 100 mg/kg.Sleep parameters were assessed to determine the average duration of each sleep stage by monitoring the electrical activity of the brain and muscles.Further,orexin neurons in the lateral hypotha-lamus(LH)and corticotropin-releasing hormone(CRH)neurons in the paraventricular hypothalamic nucleus(PVH)were ablated using viral vector surgery and electrode embedding.The excitability of LHorexin and PVHCRH neurons was evaluated through the measurement of cellular Finkel-Biskis-Jinkins murine osteosarcoma viral oncogene homolog(c-Fos)expression.Results:Rg1(12.5-100 mg/kg)augmented the duration of non-rapid eye movement(NREM)sleep phases,while reducing the duration of wakefulness,in a dose dependent manner.The reduced latency from wakefulness to NREM sleep indicates an accelerated sleep initiation time.We found that these sleep-promoting effects were weakened in the LHorexin and PVHCRH neuron ablation groups,and disap-peared in the orexin and CRH double-ablation group.Decreased c-Fos protein expression in the LH and PVH confirmed that Rg1 promoted NREM sleep by inhibiting orexin and CRH neurons.Conclusion:Rg1 increases the duration of NREM sleep,underscoring the essential roles of LHorexin and PVHCRH neurons in facilitating the sleep-promoting effects of Rg1.